Elliot Ehrich

Elliot Ehrich

UNVERIFIED PROFILE

Are you Elliot Ehrich?   Register this Author

Register author
Elliot Ehrich

Elliot Ehrich

Publications by authors named "Elliot Ehrich"

Are you Elliot Ehrich?   Register this Author

21Publications

702Reads

45Profile Views

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.

Am J Psychiatry 2019 06 8;176(6):457-467. Epub 2019 Mar 8.

Alkermes, Inc., Waltham, Mass. (Martin, Weiden, Jiang, Pathak, DiPetrillo, Silverman, Ehrich); and Hofstra Northwell School of Medicine, Hempstead, N.Y., and Zucker Hillside Hospital, Psychiatry, Glen Oaks, N.Y. (Correll).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2018.18030280DOI Listing
June 2019

Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.

Mol Psychiatry 2019 04 28;24(4):576-587. Epub 2018 Jun 28.

Department of Psychiatry, University of Utah Health Sciences Center, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41380-018-0117-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310672PMC
April 2019

Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.

Am J Psychiatry 2016 May 12;173(5):499-508. Epub 2016 Feb 12.

From the Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston; Alkermes, Inc., Waltham, Mass.; the Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia; McLean Hospital, Belmont, Mass.; and the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2015.15070921DOI Listing
May 2016

Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia.

Int Clin Psychopharmacol 2016 Mar;31(2):69-75

aDepartment of Psychiatry & Behavioral Sciences, New York Medical College, Valhalla, New York bAlkermes Inc., Waltham, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000106DOI Listing
March 2016

Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist.

J Clin Psychopharmacol 2015 Jun;35(3):242-9

From the *Altreos Research Partners Inc and †Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada; ‡Alkermes, Inc, Waltham, MA; and §DL Global Consulting and ∥Department of Medicine and Psychiatry, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415969PMC
June 2015

Evaluation of opioid modulation in major depressive disorder.

Neuropsychopharmacology 2015 May 18;40(6):1448-55. Epub 2014 Dec 18.

Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2014.330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397403PMC
May 2015

Single- and multiple-dose pharmacokinetics of samidorphan, a novel opioid antagonist, in healthy volunteers.

Clin Ther 2015 Feb 29;37(2):338-48. Epub 2014 Oct 29.

Alkermes, Inc, Waltham, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2014.10.001DOI Listing
February 2015

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.

Int J Eat Disord 2013 Apr 5;46(3):239-45. Epub 2013 Feb 5.

Lindner Center of HOPE, Research Institute, Mason, OH 45040, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eat.22114DOI Listing
April 2013

Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment.

J Clin Pharmacol 2005 Nov;45(11):1259-67

Alkermes, Inc, 88 Sidney Street, Cambridge, MA 02139-4137, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270005280199DOI Listing
November 2005

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

JAMA 2005 Apr;293(13):1617-25

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill 27599-7160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.293.13.1617DOI Listing
April 2005

Dose-effect relationships of nonsteroidal anti-inflammatory drugs: a literature review.

Clin Ther 2002 Aug;24(8):1225-91

Rheumatology and Rehabilitation Research Unit, Research School of Medicine, University of Leeds, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0149-2918(02)80033-9DOI Listing
August 2002